Dissecting NK cell development using a novel alymphoid mouse model: Investigating the role of the c-abl proto-oncogene in murine NK cell differentiation

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2761-2765

  Colucci, Francesco ^a   Soudais, Claire ^a   Rosmaraki, Eleftheria ^a   Vanes, Lesley ^b   Tybulewicz, Victor L J ^b   Di Santo, James P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; FLOW CYTOMETRY; GENE MAPPING; GENETIC REGULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENES, ABL; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2;

EID: 0033104742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wang, J. Y. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35.
2. Kipreos, E. T., and J. Y. Wang. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382.
3. McWhirter, J. R., and J. Y. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533.
4. Brown, L., and N. McCarthy. 1997. A sense-abl response? Nature 387:450
5. Welch, P. J., and J. Y. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779.
6. Sawyers, C. L., J. McLaughlin, A. Goga, M. Havlik, and O. Witte. 1994. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77:121.
7. Laneuville, P. 1995. Abl tyrosine protein kinase. Semin. Immunol. 7:255.
8. Ben-Neriah, Y., A. Bernards, M. Paskind, G. Q. Daley, and D. Baltimore. 1986. Alternative 5′ exons in c-abl mRNA. Cell 44:577.
9. Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153.
10. Schwartzberg, P. L., A. M. Stall, J. D. Hardin, K. S. Bowdish, T. Humaran, S. Boast, M. L. Harbison, E. J. Robertson, and S. P. Goff. 1991. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165.
11. Hardin, J. D., S. Boast, P. L. Schwartzberg, G. Lee, F. W. Alt, A. M. Stall, and S. P. Goff. 1995. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165:44.
12. Hardin, J. D., S. Boast, P. L. Schwartzberg, G. Lee, F. W. Alt, A. M. Stall, and S. P. Goff. 1996. Abnormal peripheral lymphocyte function in c-abl mutant mice. Cell. Immunol 172:100-7.
13. 1 hybrid mice. J. Exp. Med. 134:1513.
14. + cells. J. Immunol. 136:3124.
15. Chen, J., R. Lansford, V. Stewart, F. Young, and F. W. Alt. 1993. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. USA 90:4528.
16. Chen, J., Y. Shinkai, F. Young, and F. W. Alt. 1994. Probing immune functions in RAG-deficient mice. Curr. Opin. Immunol. 6:313.
17. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855.
18. Koo, G. C., F. J. Dumont, M. Tutt, J. Hackett, Jr., and V. Kumar. 1986. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742.
19. Wang, B., C. Biron, J. She, K. Higgins, M. J. Sunshine, E. Lacy, N. Lonberg, and C. Terhorst. 1994. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3∈ gene. Proc. Natl. Acad. Sci. USA 91:9402.
20. Di Santo, J. P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA 92:377.
21. Suzuki, H., G. S. Duncan, H. Takimoto, and T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185:499.
22. Guy-Grand, D., B. Cuenod-Jabri, M. Malassis-Seris, F. Selz, P. Vassalli. 1996. Complexity of the mouse gut T cell-immune system: identification of two distinct natural killer-T cell intraepithelial lineages. Eur. J. Immunol. 26:2246.
23. van den Broek, M. F., D. Kagi, R. M. Zinkernagel, and H. Hengartner. 1995. Perform dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514.
24. Di Santo, J. P., and H.-R. Rodewald. 1998. In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development. Curr. Opin. Immunol. 10:196.
25. Sentman, C. L., M. Y. Olsson, and K. Kärre. 1995. Missing self recognition by natural killer cells in MHC class I transgenic mice: a "receptor calibration" model for how effector cells adapt to self. Semin. Immunol. 7:109.
26. Karre, K., H. G. Ljunggren. G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2 deficient lymphoma suggests alternative defense strategy. Nature 719:675.
27. Goldman, J. P., M. P. Blundell, L. Lopes, C. Kinnon, J. P. Di Santo, and A. J. Thrasher. 1998. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain. Br. J. Hematol. 103:335.
28. Takeda, S., T. Shimizu, and H.-R. Rodewald. 1997. Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. Blood 89: 518.